Back
Expressions of CCR7 and CXCR4 Are Associated with Differentiation in Gastrointestinal Cancer
Chunhui Lu, Shiwen Chen, Feng Xu, Yiwen Chen, Qing Zhang, Yong Li
J. Cancer Ther. Vol.4 No.1, January 21, 2013  DOI: 10.4236/jct.2013.41A007
       (PDF  327K)     HTML     
Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast Cancer
Harvey Bumpers, Ming-Bo Huang, Venkat Katkoori, Upender Manne, Vincent Bond
J. Cancer Ther. Vol.4 No.4, June 06, 2013  DOI: 10.4236/jct.2013.44101
       (PDF  884K)     HTML      XML
An Up-to-Date Understanding of the “Krukenberg Tumor” Mechanism
Bikash Shah, Wenhao Tang, Shammi Karn
Adv. Reprod. Sci. Vol.4 No.2, March 31, 2016  DOI: 10.4236/arsci.2016.42005
       (PDF  238K)     HTML      XML
Receptor Conversion between Primary Tumors and Distant Metastases in 121 Cases of Metastatic Breast Cancer
Chaoying Wang, Lijun Di, Kun Yan, Huiping Li, Guohong Song, Hanfang Jiang, Shanshan Yin, Xu Liang, Ying Yan, Bin Shao, Fengling Wan, Jun Ren
Int. J. Clin. Med. Vol.4 No.2, February 26, 2013  DOI: 10.4236/ijcm.2013.42020
       (PDF  10K)     HTML     
Is Chemokine Receptor CCR9 Required for Synovitis in Rheumatoid Arthritis? Deficiency of CCR9 in a Murine Model of Antigen-Induced Arthritis
Alison Cartwright, Sophie King, Jim Middleton, Oksana Kehoe
Open J. Rheumatol. Autoimmune Dis. Vol.2 No.4, November 28, 2012  DOI: 10.4236/ojra.2012.24015
       (PDF  1131K)     HTML     
 
 
Top